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Abstract: 
Statins are known clinically by their cholesterol reduction properties through the inhibition of 
HMG-CoA reductase. There is mounting evidence suggesting a protective role of statins in 
certain types of cancer, cardiac, and vascular disease through a mechanism that extends beyond 
their lipid lowering ability. The root mechanism of damage likely involves the inflammatory 
cascade, specifically compounds known as reactive oxygen species such as the hydroxyl radical. 
However, direct evidence for the hydroxyl-scavenging capacity of pravastatin and fluvastatin, 
two forms of statins being widely used to lower LDL cholesterol, is still lacking in literature. In 
this study, electron paramagnetic resonance spectroscopy in combination with 5,5-dimethyl-1-
pyrroline N-oxide (DMPO)-spin-trapping technique was utilized to determine the abilities of 
pravastatin and fluvastatin in scavenging hydroxyl radical generated from Fe(II) with 
H2O2 system. In addition, we examined the effects of pravastatin and fluvastatin on oxidative-
induced φX-174 RF I plasmid DNA damage. We have demonstrated here for the first time that 
pravastatin and fluvastatin at physiologically relevant concentrations significantly decreased 
formation of DMPO-OH adduct indicating that both compounds could directly scavenge 
hydroxyl radicals. However, pravastatin and fluvastatin were not able to directly protect against 
oxidative DNA plasmid damage. The hydroxyl radical sequestering ability of pravastatin and 
fluvastatin reported in this study may contribute to their beneficial use in certain types of cancer 
and in cardiovascular disease. 
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Introduction 
Statins are a group of pharmacological agents that inhibit 3-hydroxy-3-methylglutaryl-
CoA (HMG-CoA) reductase, the rate limiting step of the cholesterol synthesis cascade. Since 
their introduction, statins have become very popular and are prescribed worldwide due to their 
efficacy in the treatment of lipid disorders and their generally safe side effect profile. In addition 
to their cholesterol reduction properties, recent studies have demonstrated statins can protect 
against various pathological conditions with a mechanism that likely extends beyond their lipid 
lowering abilities [1]. 
Evidence suggest statins downregulate vascular inflammation and promote cardioprotection [2]. 
Bloom et al. [3] demonstrated a decreased number of ventricular arrhythmias requiring 
defibrillation in patients on a statin with a mechanism related to decreased derivatives of reactive 
oxygen species (ROS). In addition, treatment with a statin before cardiac ablation improved 
freedom from paroxysmal and persistent atrial fibrillation [4]. The use of statins in patients with 
early aortic valve disease reduced inflammatory biomarkers [5]. The protective effects of statins 
have also been found in certain types of cancer. The favorable effects of statin in men treated 
with radiotherapy for prostate cancer [6, 7] are thought to be associated with decreased 
inflammation within prostate tumors attributable to the statin therapy [8]. Since elevated 
cholesterol has been linked with high-grade prostate cancer, prophylactic statin use may reduce 
the risk of high-grade prostate cancer due to their cholesterol lowering ability [9]. 
The common denominator for these destructive pathways is inflammation. Many studies have 
illustrated the anti-inflammatory properties of statins [10–12]. Inflammation is a cascade-like 
response to a stimulus that produces several byproducts including ROS and reactive nitrogen 
species (RNS) specifically superoxide, hydroxyl radical, and peroxynitrite [13, 14]. Among 
them, hydroxyl radicals (•OH) is one of the most reactive molecules in biological systems 
[15, 16]. However, it remains unknown whether statins are hydroxyl radical scavengers. 
Furthermore, their effects on oxidative-induced DNA damage are still lacking. In this study, 
electron paramagnetic resonance spectroscopy in combination with 5-(diethoxyphosphoryl)-5-
methylpyrroline-N-oxide (DMPO)-spin-trapping technique was utilized to study hydroxyl 
radical-scavenging activities of pravastatin and fluvastatin (Fig. 1), two forms of statins being 
widely used to lower LDL cholesterol, in a hydrogen peroxide/Fe(II) system. We have 
demonstrated here for the first time that pravastatin and fluvastatin at physiologically relevant 
concentrations significantly decreased the formation of DMPO-hydroxyl adduct (DMPO-OOH) 
in hydrogen peroxide/Fe(II) system, indicating that both compounds could directly scavenge 
hydroxyl. Using φX-174 plasmid DNA as an in vitro system, we have further investigated the 
effects of these compounds on DNA oxidative damage. Pravastatin and fluvastatin at 
physiologically relevant concentrations had no direct protection against DNA oxidative damage. 
 
Fig. 1 Structures of pravastatin and fluvastatin 
Materials and methods 
Materials 
φX-174 RF I plasmid DNA was from New England Bio-labs, Beverley, MA. Fluvastatin sodium 
≥98% (HPLC), pravastatin sodium ≥98% (HPLC), hydrogen peroxide and other chemicals were 
purchased from Sigma (St. Louis MO). 
Electron paramagnetic resonance spin-trapping assay 
Spin trap 5,5-dimethylpyrroline-N-oxide (DMPO)-spin was used to measure hydroxyl radicals 
generated by the Fenton reaction (Fe2+ + H2O2 → Fe3+ + •OH + OH−) in the presence or absence 
of various concentrations of fluvastatin or pravastatin. EPR spectra were recorded at room 
temperature with a spectrometer (Bruker D-200 ER, IBM-Bruker), operating at X-band with a 
TM cavity and capillary cell, as described previously [17]. The EPR spectrometer settings were: 
modulation frequency, 100 kHz; X-band microwave frequency, 9.5 GHz; microwave power, 
20 mW; modulation amplitude, 1.0 G (gauss); time constant, 160 s; scan time, 200 s; and 
receiver gain, 1 × 105. Reactants were mixed in test tubes to a final volume of 0.1 ml, and the 
reaction mixture was then transferred to a capillary tube for EPR spectral analysis at room 
temperature under conditions described above. Spectral simulations were performed on the EPR 
data by matching directly to the spectra as described previously [18]. 
Assay for oxidative DNA breaks 
DNA damage was measured by the conversion of supercoiled φX-174 RF I double-stranded 
DNA to open circle and linear forms [19, 20]. In summary, 0.2 μg DNA was incubated with 
H2O2 + Fe(II), SIN-1, fluvastatin or pravastatin in PBS at 37°C at a final volume of 24 μl for 
30 min. Following incubation, loading dye was added and the samples were immediately loaded 
in a 1% agarose gel containing 40 mM Tris, 20 mM sodium acetate, and 2 mM EDTA, and 
electrophoresed in a horizontal slab gel apparatus in Tris/acetate/EDTA gel buffer at 150 V for 
60 min. After electrophoresis, the gels were stained with a 0.5 mg/ml solution of ethidium 
bromide for 30 min, followed by 30 min destaining in water. The gels were then photographed 
under ultraviolet illumination and quantified using the Alpha Innotech Imaging system (San 
Leandro, CA). 
Statistical analysis 
Statistical significance of the data was calculated by analysis of variance (ANOVA). Further 
statistical analyses for post hoc comparison were done by two-tailed t test. Standard deviation 
was used to illustrate deviation. All differences of P ≤ 0.05 were considered significant. 
Results and discussion 
Hydroxyl-scavenging effects of pravastatin and fluvastatin 
EPR spectroscopy in combination with the spin trap DMPO was employed to investigate the 
hydroxyl-scavenging ability of pravastatin and fluvastatin using the Fenton reaction, a typical 
system for hydroxyl generation. As shown in Fig. 2, a spectrum of 1:2:2:1 quartet with splittings 
at a N = a H = 14.9 G was observed. These splitting constants and the 1:2:2:1 quartet are 
indicative of the DMPO-OH adduct [21]. DMPO itself did not give rise to the formation of any 
detectable spin adducts (Fig. 2, line a), indicating the high purity of this spin trap used in this 
study. Reaction mixtures were then incubated with 1, 10, or 100 μM of pravastatin and 
fluvastatin to examine hydroxyl-scavenging ability of these compounds. As shown in Figs. 2a 
and 3a (lines c–e), the intensity of the signal increased, from top to bottom, with decreasing the 
concentrations of both compounds ranging from 100 to 1 μM indicating that the scavenging 
capacity of these compounds is concentration-dependent. The percent inhibition of EPR signal 
intensity by various concentrations of these compounds is presented in Figs. 2b and 3b. As 
shown in Fig. 2b, there were significant differences in EPR signal intensity in the presence of 1–
100 μM pravastatin compared to solvent control (line b; vehicle control without pravastatin) 
(P ≤ 0.05). Fluvastatin at 10–100 μM, while not 1 μM, significantly inhibited the intensity of the 
spectrum in a concentration-dependent manner indicating that higher concentrations of 
fluvastatin were necessary for the effective scavenging of hydroxyl radical (Fig. 3b) (P ≤ 0.05). 
 
Fig. 2 Effect of pravastatin on hydroxyl radicals generated from the Fenton reaction. EPR spectra 
of DMPO-OH observed during the reaction of 200 μM ferrous sulfate and 200 μM 
H2O2 containing 100 μM DMPO, in the presence or absence of pravastatin. a Line a 100 μM 
DMPO alone without FeSO4, H2O2, and test compounds; line b 200 μM FeSO4 and 200 μM 
H2O2; line c 200 μM FeSO4 and 200 μM H2O2, and 1 μM pravastatin; line d 200 μM FeSO4 and 
200 μM H2O2, and 10 μM pravastatin; line e 200 μM FeSO4 and 200 μM H2O2, and 100 μM 
pravastatin. EPR measurement conditions were as described in “Materials and methods” section. 
Data represent similar results from three independent experiments. b Signal intensity at 3480 G 
was expressed as mean ± SD from three separate experiments (*P < 0.05 vs. control) 
 
Fig. 3 Effect of fluvastatin on hydroxyl radicals generated from the Fenton reaction. EPR spectra 
of DMPO-OH observed during the reaction of 200 μM ferrous sulfate and 200 μM 
H2O2 containing 100 μM DMPO, in the presence or absence of fluvastatin. a Line a 100 μM 
DMPO alone without FeSO4, H2O2 and test compounds; line b 200 μM FeSO4 and 200 μM 
H2O2; line c 200 μM FeSO4 and 200 μM H2O2, and 1 μM fluvastatin; line d 200 μM FeSO4 and 
200 μM H2O2, and 10 μM fluvastatin; line e 200 μM FeSO4 and 200 μM H2O2, and 100 μM 
fluvastatin. EPR measurement conditions were as described in “Materials and methods” section. 
Data represent similar results from three independent experiments. b Signal intensity at 3480 G 
was expressed as mean ± SD from three separate experiments (*P < 0.05 vs. control) 
The potential vascular effects of statins have been documented in various animal models and 
clinical patients [22–24]. Statins were found to reduce generation of ROS by the inhibition of 
vascular NAD(P)H oxidase and myeloperoxidase and by the up-regulation of antioxidant 
enzymes such as catalase and paraoxonase [25]. Statins inhibit Rho-GTPase-dependent platelet–
neutrophil interaction, which in part prevent neutrophil oxygen free radical release [26]. They 
also decrease respiratory burst activity of human neutrophils [27]. These previous studies 
indicate that the protective actions of statins could be due to their antioxidant activity, however, 
the exact mechanism(s) underlying their protective actions remains to be elucidated. We have 
demonstrated here for the first time that pravastatin and fluvastatin at physiologically relevant 
concentrations significantly decreased the formation of DMPO-hydroxyl adduct (DMPO-OH) in 
hydrogen peroxide/Fe(II) system, indicating that both compounds could directly scavenge 
hydroxyl radicals. Hydroxyl radicals play a pathogenetic role in a variety of diseases including 
inflammatory vascular disease and heart failure [28–30]. It is noted that the concentrations of 
pravastatin and fluvastatin used in this study could be physiologically relevant. For example, 
Siekmeier et al. [31] reported that the physiological concentration of fluvastatin in the cytoplasm 
could reach up to 5000 ng/ml (11.5 μM). Therefore, the potential capacities of statins in 
scavenging of hydroxyl radicals reported in this study could be important in ameliorating various 
diseases. 
Effect of pravastatin and fluvastatin on hydroxyl radical-mediated DNA strand break 
In φX-174 RF I plasmid DNA, induction of single-strand breaks to the supercoiled double-
stranded DNA leads to formation of open circle DNA, while the formation of a linear form of 
DNA is indicative of double-strand breaks suggesting further damage to the open circle DNA 
[32]. The highly reactive hydroxyl radicals are known to damage a wide array of molecules in 
cells and critically participate in the induction of DNA damage. There is a pool of intracellular 
iron known as catalytic iron, which may contribute to hydroxyl generation through the Fenton 
reaction [15]. In this cortex, human studies have demonstrated a link between increased catalytic 
iron and many chronic diseases including cardiovascular diseases [33–35]. Thus, the Fenton 
reaction, involving Fe2+ and H2O2 for hydroxyl radical’s generation was used to investigate 
whether pravastatin and fluvastatin can protect against DNA damage. 
As shown in Fig. 4a, c (lane 2), incubation of DNA with H2O2 and Fe(II) for 30 min resulted in 
increased formation of open circle DNA, indicating that DNA breaks can be induced by the 
H2O2/Fe(II) system. Although pravastatin and fluvastatin at various concentrations exhibited 
hydroxyl-scavenging activities, the addition of these compounds at the concentrations ranging 
from 1 to 100 μM to H2O2/Fe(II) has no significant inhibition of the conversion of supercoiled 
DNA to the open circle form (Fig. 4b, d). These results indicate that pravastatin and fluvastatin 
do not effectively protect against H2O2/Fe(II)-mediated DNA damage. The reason of this result is 
not clear because the mechanism(s) of DNA damage by Fenton reaction and action of these 
compounds remains unknown. One possible explanation is that both compounds could exhibited 
antioxidant activities by donating one of their own electrons to hydroxyl radicals and then 
become another radical that could further cause DNA damage. 
 
Fig. 4 Effects of pravastatin and fluvastatin on H2O2/Fe(II)-mediated DNA strand breaks. The 
φX-174 plasmid DNA was incubated with 100 μM H2O2 + 100 μM FeSO4 (a, b) or 10 μM 
H2O2 + 10 μM FeSO4 (c, d) in the presence or absence of the indicated concentrations of 
pravastatin or fluvastatin in PBS at 37°C for 30 min. (a, c) A representative agarose gel picture, 
demonstrating effects of increasing concentrations of pravastatin and fluvastatin on DNA 
damage; (b, d) quantitative analysis of DNA damage demonstrated in a and c, respectively. The 
DNA strand breaks were determined as described in the “Materials and methods” section. The 
control was φX-174 plasmid DNA incubated in PBS in the absence of any added 
agents. OC open-circular DNA conformation; SC supercoiled DNA conformation. Data represent 
mean ± SD of three independent experiments 
Effect of pravastatin and fluvastatin on SIN-1-mediated DNA strand break 
Peroxynitrite is a potent oxidant capable of causing DNA damage. Statins are reported to show 
anti-atherosclerotic effects mediated by peroxynitrite [36]. At a physiological pH, SIN-1 is 
known to undergo auto-oxidation to produce equal molar nitric oxide and superoxide, leading to 
the formation of peroxynitrite [37,38]. This system is often used in the examination of 
peroxynitrite on biological systems [20, 37]. Thus, SIN-1 was used to further investigate whether 
pravastatin and fluvastatin can protect DNA damage caused by peroxynitrite. As shown in Fig. 5, 
a significant formation of open-circular form of DNA was observed following incubation of the 
plasmid DNA with 250 μM SIN-1 for 30 min (Fig. 5). However, the addition of pravastatin and 
fluvastatin at the indicated concentrations do not effectively protect against SIN-1-mediated 
DNA damage suggesting that those compounds do not directly scavenge peroxynitrite generated 
from SIN-1 autooxidation or inhibit the auto-oxidation of SIN-1 to produce peroxynitrite. 
 
Fig. 5 Effects of fluvastatin or pravastatin on SIN-1 mediated DNA strand breaks. The φX-174 
RF I plasmid DNA was incubated with 250 μM SIN-1 in the presence or absence of the indicated 
concentration of fluvastatin or pravastatin in PBS at 37°C for 30 min. The DNA strand breaks 
were determined as described in “Materials and methods” section. a A representative agarose gel 
picture, demonstrating effects of increasing concentrations of pravastatin and fluvastatin on DNA 
damage; b quantitative analysis of DNA damage demonstrated in a. OC open-circular DNA 
conformation; SC supercoiled DNA conformation. Data represent mean ± SD of three 
independent experiments 
In summary, this study demonstrates for the first time that pravastatin and fluvastatin at 
physiologically relevant concentrations exhibited hydroxyl radicals scavenging activities using a 
sensitive and specific technique of EPR spin-trapping method. Substantial evidence suggests that 
hydroxyl radicals are involved in the vascular pathology associated with atherosclerosis. Thus, 
the potential capacities of statins in scavenging of hydroxyl radicals activity reported in this 
study could be important in ameliorating various diseases. Further studies are essential to 
elucidate the exact mechanism of their protective actions observed in human clinical trials and 
animal models. 
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